Background. Following an acute coronary syndrome, combined CT and PET with 18 F-NaF can identify coronary atherosclerotic plaques that have ruptured or eroded. However, the processes behind 18 F-NaF uptake in vulnerable plaques remain unclear. Methods and Results. Ten patients with STEMI were scanned after 18 F-NaF injection, for 75 minutes in a Siemens PET/MR scanner using delayed enhancement (LGE). They were then scanned in a Siemens PET/CT scanner for 10 minutes. Tissue-to-background ratio (TBR) was compared between the culprit lesion in the IRA and remote non-culprit lesions in an effort to independently validate prior studies. Additionally, we performed a proof-of-principle study comparing TBR in scar tissue and remote myocardium using LGE images and PET/MR or PET/CT data. From the 33 coronary lesions detected on PET/CT, TBRs for culprit lesions were higher than for non-culprit lesions (TBR 5 2.11 ± 0.45 vs 1.46 ± 0.48; P < 0.001). Interestingly, the TBR measured on the PET/CT was higher for infarcted myocardium than for remote myocardium (TBR 5 0.81 ± 0.10 vs 0.71 ± 0.05; P 5 0.003). These results were confirmed using the PET/MR data (TBR 5 0.81 ± 0.10 for scar, TBR 5 0.71 ± 0.06 for healthy myocardium, P 5 0.03).
INTRODUCTION
Acute myocardial infarction (AMI) is a leading cause of death and disability worldwide. AMI occurs when rupture or erosion of coronary atheroma leads to thrombus formation and sudden occlusion of a major epicardial coronary artery. 1 While coronary atheromata are commonly present in many middle-aged and older adults, certain atheromatous plaques are more susceptible to rupture and erosion. Termed 'vulnerable plaques,' these atheromata are histologically defined by a large lipid-rich core and thin overlying fibrous cap. 2, 3 The medical imaging community has recognized that mere identification of atheromatous plaques 4 is insufficient as many atheromatous plaques are stable and not prone to rupture or erosion. 5, 6 It is therefore of great interest to the community to develop tools to better identify vulnerable plaques as the presence of these plaques may indicate an increased risk of AMI, therefore prompting escalation of medical treatment or targeted mechanical stabilization of vulnerable plaques by selective coronary stenting.
Many modalities presently developed to identify vulnerable coronary plaques are invasive in nature, requiring the insertion of physical devices into a patient's coronary arteries. 7, 8 Despite the superior spatiotemporal resolution of these invasive modalities, they carry a small but definite risk of causing coronary artery injury and AMI. As such, non-invasive modalities to identify vulnerable coronary plaques are a key unmet need in coronary artery imaging. Recently, non-invasive PET-CT has been used to identify high-risk plaques using 18 F-NaF. 9 , 10 Joshi et al. 11 showed that the Tissueto-Background ratio (TBR) for culprit plaques was significantly higher than for non-culprit plaques (1.66 vs 1.24) on 18 F-NaF PET/CT imaging of 40 patients with recent myocardial infarction.
It is presently unclear if 18 F-NaF has other potential uses in cardiac imaging. While it is acknowledged that 18 F-NaF can detect culprit coronary atheromata, the mechanism behind this detection remains unclear. More recently, Irkle et al. 12 demonstrated preferential binding of 18 F-NaF to microcalcification. As prior studies have shown varying degrees of calcification in previously infarcted myocardium, we hypothesized that 18 F-NaF could detect scar tissue arising from myocardial infarction. Moreover, 18 F-NaF may possibly target apoptosis, as demonstrated in rat imaging, 13 or macrophage infiltration and necrosis, as suggested by histological studies of carotid artery plaques, 11 processes that are common to both atherosclerotic plaque formation and myocardial infarction. We therefore sought first to independently validate the use of 18 F-NaF PET/CT imaging for the detection of high-risk coronary atheromata. Using 18 FNaF PET/MR imaging, we then sought to quantify the uptake of 18 F-NaF in myocardial scar tissue relative to remote healthy myocardium to add understanding of the common processes between infarction and atheromata.
MATERIALS AND METHODS

Study Population
For this pilot study, we enrolled ten consecutive patients presenting with STEMI undergoing primary (emergency) percutaneous coronary intervention (PCI) at the National University Heart Centre Singapore. STEMI was determined by a typical history of ischemic chest pain or angina equivalent symptoms, new ST elevation at the J point in at least 2 contiguous leads of C2 mm (0.2 mV) in men or C1.5 mm (0.15 mV) in women in leads V2-V3 and/or of C1 mm (0.1 mV) in other contiguous chest leads or the limb leads, accompanied by a typical rise and/or fall of cardiac troponin. 14 All patients had an acute occlusion of an infarct-related artery (IRA) on coronary angiography and underwent emergency PCI with stent placement within 12 hours of symptom onset. After PCI, consented patients were screened for eligibility and were then scanned at a median of 13.5 days (range 9-24) after the acute event on the PET/MR followed immediately by PET/CT.
We excluded patients with MR contraindications such as metallic implants, pacemakers, or claustrophobia. Additionally, we excluded patients with severe renal and liver impairment, significant valvular heart disease, and a history of malignancy.
The study was approved by the National Healthcare Group Domain Specific Review Board (DSRB reference number 2013/ 00248), and written informed consent was obtained from all patients.
See related editorial, pp. 2012-2015 PET/MR Image Acquisition and Reconstruction
All subjects were first scanned on a Biograph mMR PET-MR scanner (Siemens Healthineers, Erlangen, Germany) for 75 minutes. MRI and PET scans were performed simultaneously on a single bed centered over the heart. The PET-MRI scan was started immediately after intravenous injection of 2.95 ± 0.21 mCi 18F-NaF. PET data were reconstructed from the last 15 minutes (60-75 minutes after injection) using an iterative reconstruction (Siemens OP-OSEM algorithm, 3 iterations, 21 subsets, matrix size 344 9 344 with Point Spread Function 15 correction) without ECG or respiratory gating to decrease the level of noise. The UMAP was created from a Dixon MRI sequence acquired at the beginning of the PET recording. The reconstructed images were smoothed with a 2-mm FWHM Gaussian filter, matching the voxel dimension of 2 9 2 9 2 mm. 18F-NaF uptake in the scar and remote myocardium was quantified by the standardized uptake value (SUV).
Cardiovascular Magnetic Resonance (CMR) Protocol and Measurements
Image acquisition. In addition to the localizer, the MRI cardiac imaging protocol included a breath-hold CINE steadystate free precession (SSFP) short-axis view covering both the right ventricle (RV) and the left ventricle (LV). Delayed enhancement (LGE) short-axis images were acquired 10 minutes after a 0.2 mmol/kg GADOVIST injection. Sequential parameters of the LGE acquisition were the following: TR = 4.1 ms, Average R-R interval = 990 ms, TE = 1.56 ms, Slice thickness = 8 mm, Gap = 20%, FOV = 276 9 340 mm, Matrix = 133 9 256, Flip angle = 20, Inversion time = subject-specific calculation using TI scout, Image resolution = 1.33 9 1.33 9 10 mm.
Image analysis. All CMR sequences were analyzed jointly by two trained image analysts using the 510k FDA cleared software Segment version 1.9 R3556. 16 Left ventricular (LV) segmentation of the endocardium and epicardium was performed automatically on all timeframes of the short-axis CINE stack. Manual adjustment of the contours was performed if necessary, following the SCMR guidelines. 17 In addition, LGE images were analyzed by delineating the LV endocardium and epicardium manually and extracting the scar tissue automatically using Otsu's threshold. 18 
PET/CT Image Acquisition and Reconstruction
Of the ten subjects who underwent PET/MR scanning, two subjects declined subsequent PET/CT scanning. The remaining eight subjects were then immediately transferred to a Biograph mCT PET/CT scanner (Siemens Healthineers, Erlangen, Germany). A non-enhanced coronary artery calcium score CT scan (120 kV, 120 quality reference mAs, CareDose, 300-ms exposure time, 128 9 0.6 mm collimation, non-triggered acquisition) and a low-dose CT attenuation correction scan were first performed using the 128-row CT scanner in the PET/CT system. The calcium scan was reconstructed at a slice thickness of 3 mm using an iterative reconstruction (Siemens SAFIRE) to allow high-resolution imaging of the coronary arteries.
The CT scans were immediately followed by a 10 minutes PET scan (one bed position centered over the heart). The scan time was limited to 10 minutes to ease the protocol for the patients who previously underwent 75 minutes of PET/MRI scanning. The PET scan was started at least 90 minutes post 18 FNaF injection (108 ± 21 minutes) and was reconstructed using an iterative reconstruction (Siemens OP-OSEM algorithm, 3 iterations, 21 subsets, 2 mm pixel size, 2 mm FWHM Gaussian filter), with attenuation and scatter corrections included as well as Time of Flight 19 and Point Spread Function 15 correction. Although the PET scan was acquired using respiratory and cardiac gating, the gated information was not used in the reconstruction as it resulted in images with suboptimal count statistics.
Tissue-To-Background Ratio Calculation
Coronary atheromata TBR from PET/ CT. Calcium regions within the arteries were delineated manually on the CT image, having higher intensities than surrounding blood as shown in Figure 1 . Additionally, each vessel containing at least one calcium region was partly segmented manually from axial slices of the 3D CT image. Hybrid PET-CT acquisition ensures the direct transposition of these Regions of Interest (ROIs) on the PET image, therefore enabling the automatic measurement of SUV within each region. This direct transposition of the ROIs does not guarantee an optimal quantification of SUV due to the rapid motion and small size of the atheromata as it has been demonstrated before. 20 Since a consensus on solving these misregistration problems has not been validated yet, the authors decided to use a simple approach and measure the TBR of each calcium ROI as already validated by Josh et al. 11 It is defined as the ratio between the calcium region maximum SUV over the corresponding vessel (excluding the calcium ROIs) mean SUV:
Myocardial infarct TBR from PET/MR. In order to correct possible misalignment between the LGE images acquired half way through the CMR protocol on 10-15 breath-holds, and the PET/MR image acquired continuously over 15 minutes toward the end of the CMR protocol, a first automatic registration was performed. As described before,
LGE short-axis images were first analyzed in order to extract the scar regions and the healthy myocardium regions. The images and resulting masks were then resampled to an isotropic resolution (1.33 9 1.33 9 1.33 mm) for a better fit with the PET image. As described in Figure 2 (left), the Dixon (in-phase) image acquired along the PET is first resampled to the same short-axis acquisition plane as the LGE image to ease the registration between the two images. An in-house algorithm (developed using ITK libraries) using well validated mutual information metric 21 to perform the rigid 3D registration was used. Despite the different image intensities in both images (the myocardium is not visible on Dixon), the registration was successful as shown in Figure 2 (left).
After automatic realignment of LGE and Dixon, registered scar and remote healthy myocardium ROIs were reported directly on the Dixon (for verification) and the PET image for SUV quantification. The TBR in the myocardium was defined differently from the TBR in the atheromata, as the mean SUV within the ROI (scar or remote myocardium) divided by the mean SUV within the left ventricle blood pool away from the walls:
The mean SUV of the ROI was considered instead of the max SUV to account for the large scar and remote myocardium regions compared to the atheromata ROIs. Although the blood pool may show local turbulence, the averaged value of blood pool SUV acquired over 15 minutes of PET acquisition was chosen to normalize the infarct (and remote myocardium) uptake since it is assumed to be consistent across patients who underwent an identical protocol.
Myocardial infarct TBR from PET/CT. As the PET data acquired on PET/CT were of higher quality than the PET-MRI data, myocardial infarct TBRs were also measured on the PET/CT to confirm the results. As described in Figure 2 (right), the LGE MRI images had first to be aligned to the PET/ CT images. First the CT images were resampled on the scanner software Siemens SAFIRE in order to obtain short-axis views (2 mm thickness), and 2 chamber and 4 chamber views corresponding to the MRI LGE image orientation. Then, MedINRIA 1.9 22 image fusion software was used for a manual landmark-based rigid registration to align the isoresampled LGE image and masks (obtained from the LGE to PET/MR registration step) to the resampled CT image chosen as the reference image. The junctions between outflow and inflow vessels were used as landmarks for the co-registration as well as the apex tip. Similarly to the PET/MR registration, the resulting transformation was then applied to deform the myocardium and scar ROIs. 
Angiography Examination
Patients underwent emergent coronary angiography and primary percutaneous coronary intervention for STEMI via transradial or transfemoral access. Coronary angiograms were acquired on a Siemens biplane Artis system (Siemens, Munich, Germany) using standardized tomographic views of right anterior oblique caudal, anterior posterior cranial, left anterior oblique cranial, and left anterior oblique caudal for the left coronary system; and left anterior oblique cranial and right anterior oblique for the right coronary system. The volume of contrast (Omnipaque) used for each coronary angiogram was typically between 25-50 mL. All patients underwent manual thrombectomy, balloon angioplasty, and coronary stent implantation as directed by the primary operator.
Culprit plaques were spatially defined by the presence of an occlusive or subocclusive lesion within the IRA corresponding to electrocardiographic and echocardiographic localization. Culprit lesions on coronary angiography were then mapped to corresponding calcium regions on the CT image, and each calcium region assigned a culprit or nonculprit label.
Statistical Analysis
Coronary atheromata. The TBR of identified culprit and non-culprit lesions were compared statistically using a 2-tailed Student's t test and the mean and standard deviation (SD) for culprit vs non-culprit plaques recorded. The effect size (d) using Cohen's definition (difference of the group means divided by the average standard deviation) was also calculated in order to judge the magnitude of the difference (d C 0.8 is considered a large difference). 23 From the mean and standard deviation of the culprit and non-culprit plaque Left PET/MR description of the LGE to PET/MR registration that leads to the measurement of scar vs heathy myocardium TBR. Right PET/CT for the same patient, description of the LGE to PET/CT registration. With both modalities, higher uptake is noticeable in the scar (green area) compared to the remote myocardium (red). TBR, 95% confidence intervals (CI) were computed (mean ± 1.96 SD). Using these non-overlapping intervals, a cutoff value was defined as the mean between the lower bound of the 95% CI of culprit plaques and the higher bound of the 95% CI of non-culprit plaques. Sensitivity and specificity values to classify high-and low-risk plaques with this cutoff value were then calculated.
Myocardial infarct. TBR between scar and remote myocardium were compared statistically using a 2-tailed Student's t test and Cohen's effect size to account for the small sample size. Statistical software package in Matlab R2013b was used for all analyses and a 2-sided a of 5% was considered statistically significant. A Pearson's correlation was also established between the PET/MR and PET/CT SUVs.
RESULTS
Baseline Characteristics
The cohort comprised of 9 men and 1 woman with a mean age of 48 ± 7 years. All received a loading dose of aspirin and ADP-receptor inhibitor before the coronary intervention and had a median door-to-balloon time of 42 minutes (interquartile range 24). Median peak Troponin I was 69.5 ng/mL (interquartile range 45.6), indicating significant myocardial damage. Two subjects declined to undergo PET/CT after the first PET/MRI scan. Baseline and CMR characteristics are shown in Table 1 .
Visual Analysis
Coronary atheromata. Atheromatous plaques were segmented on the CT calcium scoring image as regions of high intensity (white) within the coronaries (see Figure 1C) . Hybrid PET/CT imaging allowed automatic co-registration of the coronary anatomy and the PET image. This can however be imperfect due to patient, respiratory, and cardiac motions. Visual distinction of vulnerable plaques was challenging due to the small size of the plaques, the limited resolution of the PET image, as well as respiratory and cardiac motion, leading to high partial volume effect (see Figure 1D) . In the example shown in Figure 1 , the culprit (high risk) plaque as assessed by angiography corresponds to ROI1, while ROI2 was diagnosed as a low-risk plaque. On the PET image, a visual difference in uptake between the two ROIs is noticeable; however, the maximal SUV of the culprit plaque is of the same order of magnitude as the noise in the surrounding blood. This non-specific uptake renders the detection of vulnerable plaques impossible if SUVs of plaques are compared without normalization to background.
Myocardial scar. Report of the myocardium and scar ROIs after registration of the LGE image and the PET/CT was visually successful (as assessed by two independent observers) on all cases allowing confidence in the measurements. Similarly, the automatic registration of LGE and Dixon (to align with PET/MR) was necessary for 2 of the 10 cases and allowed to correct for patient motion. The other eight patients showed more stillness during the scan leading to already aligned images (as assessed by two independent observers) for which the automatic registration showed no improvement.
Visual distinction of scar tissue on the PET images (both PET/MR and PET/CT) was as challenging as for the atheromata. An example is shown in Figure 2 (left for PET/MR and right for PET/CT on the same patient) in which most parts of the scar have higher uptake than the average myocardium. However, partial volume effect, breathing, and cardiac beating reduce the uptake to a low value. One can also notice that the uptake in the blood pool is globally higher than in the myocardium. Once again the uptake is not specific to the scar and similar uptake is observed in the turbulent blood pool or surrounding tissue. For a better comparison of regional muscle uptake, PET images were masked to the full myocardium and overlaid on LGE images as shown in Figure 3 . Clear distinction can be made between healthy and infarct uptake. However, as one can notice, the uptake is not homogeneous within the scar region.
Parametric Comparison
Coronary atheromata. From the 33 detected lesions on CT, 8 were identified as being culprit on the standard coronary angiogram, 1 for each patient undergoing PET/CT. The TBR of the culprit lesions was found significantly higher than the TBR for non-culprit lesions (Figure 4 , left) with an average value of 2.11 for culprit (±0.42) and 1.36 (±0.30) for non-culprit (P value \ 0.001, d = 1.77) as shown in Table 2 . Considering only non-overlapping confidence intervals, a threshold for the classification of high-risk and low-risk lesions was defined at 1.70. This led to a specificity of 72%, a sensitivity of 87.5%, and an accuracy of 75.7% for detecting culprit coronary atheromata in these eight patients.
Myocardial scar. Nine of the ten patients had clear visible zones of scar tissue defined on the LGE image. In the patient without clear LGE, the IRA was the right posterior descending artery (RPDA), which is the likely reason for the absence of definite scar. Scar percentages are reported in Table 3 along with the TBR and SUV for scar relative to remote healthy myocardium for each patient and each image modality. The TBR was found to be significantly higher in scar tissue than in the remote healthy myocardium with an average value of 0.87 (±0.10) for scar and 0.72 (±0.05) for remote myocardium (P value = 0.003, d = 1.86) on the PET/ CT for the eight patients (Figure 4, right) . Similarly, despite lower image quality of the PET/MR, the TBR was also found significantly higher in scar tissue (TBR = 0.81 ± 0.10) than in remote myocardium (TBR = 0.72 ± 0.06), (P value = 0.03, d = 1.55) for the ten patients. Additionally, including only the eight patients that underwent both PET/CT and PET/MR, SUV measured with PET/CT and PET/MR showed significant Pearson's correlations of 0.75 for scar and 0.71 for remote myocardium despite the small number of patients. From the PET/MR data, there was no significant correlation between the size of the scar tissue and the uptake (P value = 0.91, R = -0.04 between scar size and TBR scar, P value = 0.33, R = -0.36 between scar size and SUV scar) consistent with the measure being averaged on the scar zone. There was also no correlation between the scar size or the uptake with respect to the PCI-to-scan time (P value = 0.28, R = -0.40 between TBR scar and PCI-to-scan time; P value = 0.33, R = -0.36 between SUV scar and PCIto-scan time; P value = 0.34, R = -0.35 between scar size and PCI-to-scan time).
DISCUSSION
Our study results first confirm previous findings of successful 18 F-NaF differentiation of culprit coronary atheromata in the IRA of patients with recent STEMI, despite noisy PET images and a non-optimal protocol that do not allow direct visual assessment. As shown, and contrary to Joshi et al., 11 a distinct identification of culprit plaques on the PET images was hardly noticed in our study despite the highly significant TBR differences. This difference may be due to respiratory and cardiac motion, small size of the lesions leading to high partial volume effect, or insufficient injected activity. A longer scan time would have allowed ECG and respiratory gating, probably leading to more accurate results, less partial volume effect, and improved image quality. Additionally, new reconstruction algorithms can be thought of to reduce the noise level (for instance, the work by Rubeaux et al. 20 ). Nevertheless, the amount of noise from all these factors affects the TBR of all plaques, making the culprit vs non-culprit comparison relevant. In addition, this pilot study included a small cohort of patients as an initial proof-of-concept of concomitant coronary and myocardial 18F-NaF PET imaging. Despite the limitations of our protocol, the limited study size, and the unspecific uptake, the difference in TBR was highly significant proving once more the potential of such an approach to differentiate between atheromata. As for all other similar studies, patients were scanned after PCI which is likely to have affected the plaque prior to scanning. Joshi et al.'s histological validation 11 indicates nonetheless that this is not a major limitation. The accuracy of only 76%, however, tends to confirm previous skepticism on the clinical value of the method since more than one plaque might have ruptured unnoticed. 8 It is therefore clear that more research is still required before 18F-NaF PET imaging can be used as a diagnostic tool and more validation needed in order to establish a PET threshold to define a vulnerable plaque. For now, as described in the ''myth of the vulnerable plaque'' by Arbab-Zadeh and Fuster, 24 a more sensible approach will be to treat systemic risk rather than focus on specific high-risk plaques.
The main contribution of this study was to identify, for the first time in humans, simultaneous 18 F-NaF uptake in myocardial scar in the territory supplied by the IRA using both PET/CT after registration with LGE and PET/MR. Co-registration with CMR enabled structural myocardial information otherwise unavailable from the CT images to be incorporated into the PET/CT analysis and directly compared with the PET/MR analysis.
Despite spillage from the left ventricular blood pool that could affect the SUV for both myocardial scar (mainly transmural in our study) and remote myocardium, partial volume effect due to respiratory and cardiac motion, and potential misregistration between non-contrast CT and MRI and between PET/MR and LGE, we demonstrated twice that 18 F-NaF is taken up by both culprit coronary atheromata and myocardial scar tissue. PET/MRI acquisition does not include Time of Flight, and the reconstruction is based on a UMAP of lower accuracy than what is obtained from a CT scan. Despite these limitations, the results correlated with the PET/CT results, which strengthens our hypothesis that 18 F-NaF targets myocardial scar significantly. Additionally, the non-homogenous uptake of 18 F-NaF in the myocardial infarct seems to indicate various processes TBR, Tissue-to-background ratio ** P value \ 0.01, * P value \ 0.05 Previous studies intended to explain why 18 F-NaF binds to ruptured or vulnerable plaque offer the following hypothesis: atherosclerotic vascular calcification is a cellular response to necrotic and chronic inflammatory stimulus, 11 therefore directly linked to inflammation. Additionally, fluoride ions are incorporated in the process of microcalcification. 5, 6 Recently Irkle et al. 12 differentiated stable macrocalcification from high-risk microcalcification, therefore explaining the preferred binding of 18 F-NaF to culprit plaques. Moreover, Irkle et al. 12 proved that this specific uptake in the culprit plaques did not correlate with any markers of inflammation which therefore excludes the hypothesis that 18 FNaF targets inflammation resulting from stent injury in the artery or any other inflammation processes.
Studies have identified calcification of infarcted myocardium on CT images and in postmortem examinations. 25 In canine models of AMI, permanent coronary ligation did not increase the uptake of radiolabeled 45Ca-CaCl, but ischemia followed by reperfusion led to an 18-fold increase in calcium uptake in the injured myocardium. 26, 27 Calcium uptake is postulated to be an active process associated with mitochondrial accumulation of calcium into dense intramitochondrial granules of calcium phosphate. Mitophagy of cardiomyocytes is often triggered by massive calcium influx into cardiomyocyte mitochondria exposed to ischemiareperfusion injury. The uptake of mitochondrial is a feature of irreversible cellular injury, and may be related to defects in mitochondrial membrane permeability. Moreover, increased uptake calcium could also be due to retention of calcific deposits in the extracellular space present due to myocyte death or from the myocyte necrosis process itself. 28 Our study did not include histological findings to determine with certainty the common processes between myocardial infarct and culprit atheromata uptake, but we hypothesize that many of the cell death mechanisms in atherosclerotic plaque disruption are common to myocardium exposed to ischemia-reperfusion injury.
NEW KNOWLEDGE GAINED
The use of 18 F-NaF PET/CT imaging to detect highrisk coronary lesions in patients with STEMI is confirmed in a small Asian population. The comparison of 18 F-NaF uptake in myocardial scar tissue with remote healthy myocardium shows, for the first time in humans, that 18 F-NaF also binds to myocardial scar tissue. These data serve as proof-of-principle that first, pathobiological processes involving microcalcification may be common to both atherosclerotic plaque disruption and myocardial infarction and second, 18 F-NaF PET/CT could be potentially applied to simultaneous coronary and myocardial imaging applications to quantify both vulnerable plaque burden and myocardial scar tissue.
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